nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Docetaxel—melanoma	0.172	0.309	CbGbCtD
Sildenafil—CYP1A1—Dacarbazine—melanoma	0.0916	0.164	CbGbCtD
Sildenafil—CYP2E1—Dacarbazine—melanoma	0.0707	0.127	CbGbCtD
Sildenafil—CYP3A4—Temozolomide—melanoma	0.051	0.0916	CbGbCtD
Sildenafil—CYP2D6—Vemurafenib—melanoma	0.044	0.079	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—melanoma	0.0328	0.0589	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0328	0.0589	CbGbCtD
Sildenafil—PDE5A—clitoris—melanoma	0.0297	0.258	CbGeAlD
Sildenafil—CYP3A4—Vemurafenib—melanoma	0.028	0.0502	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—melanoma	0.0246	0.0442	CbGbCtD
Sildenafil—PDE6G—optic choroid—melanoma	0.0203	0.176	CbGeAlD
Sildenafil—CYP3A4—Docetaxel—melanoma	0.00959	0.0172	CbGbCtD
Sildenafil—PDE6C—eye—melanoma	0.00721	0.0625	CbGeAlD
Sildenafil—PDE6C—retina—melanoma	0.00715	0.0619	CbGeAlD
Sildenafil—PDE6H—eye—melanoma	0.00425	0.0368	CbGeAlD
Sildenafil—PDE6H—retina—melanoma	0.00421	0.0365	CbGeAlD
Sildenafil—PDE6C—head—melanoma	0.00409	0.0355	CbGeAlD
Sildenafil—PDE6G—eye—melanoma	0.00409	0.0354	CbGeAlD
Sildenafil—PDE6G—retina—melanoma	0.00405	0.0351	CbGeAlD
Sildenafil—PDE5A—endothelium—melanoma	0.00329	0.0285	CbGeAlD
Sildenafil—PDE5A—blood vessel—melanoma	0.00304	0.0263	CbGeAlD
Sildenafil—ABCC5—hair follicle—melanoma	0.00296	0.0257	CbGeAlD
Sildenafil—PDE6H—head—melanoma	0.00241	0.0209	CbGeAlD
Sildenafil—PDE6G—head—melanoma	0.00232	0.0201	CbGeAlD
Sildenafil—CYP1A1—skin epidermis—melanoma	0.00193	0.0167	CbGeAlD
Sildenafil—PDE6G—lymph node—melanoma	0.00163	0.0141	CbGeAlD
Sildenafil—PDE5A—eye—melanoma	0.00162	0.014	CbGeAlD
Sildenafil—PDE5A—retina—melanoma	0.0016	0.0139	CbGeAlD
Sildenafil—ABCC5—retina—melanoma	0.00147	0.0127	CbGeAlD
Sildenafil—ADORA2A—head—melanoma	0.00101	0.00873	CbGeAlD
Sildenafil—ABCC10—mammalian vulva—melanoma	0.00098	0.00849	CbGeAlD
Sildenafil—PDE5A—head—melanoma	0.000918	0.00795	CbGeAlD
Sildenafil—PDE5A—lymph node—melanoma	0.000643	0.00557	CbGeAlD
Sildenafil—CYP1A1—skin of body—melanoma	0.000598	0.00518	CbGeAlD
Sildenafil—ABCC5—lymph node—melanoma	0.000588	0.00509	CbGeAlD
Sildenafil—ABCC4—head—melanoma	0.000582	0.00504	CbGeAlD
Sildenafil—CYP1A1—mammalian vulva—melanoma	0.000545	0.00472	CbGeAlD
Sildenafil—ABCC10—lymph node—melanoma	0.000491	0.00425	CbGeAlD
Sildenafil—ABCC4—lymph node—melanoma	0.000407	0.00353	CbGeAlD
Sildenafil—CYP1A1—head—melanoma	0.00039	0.00338	CbGeAlD
Sildenafil—CYP2E1—head—melanoma	0.000356	0.00308	CbGeAlD
Sildenafil—Malaise—Bleomycin—melanoma	0.000323	0.00158	CcSEcCtD
Sildenafil—Flushing—Temozolomide—melanoma	0.000322	0.00158	CcSEcCtD
Sildenafil—Cardiac disorder—Temozolomide—melanoma	0.000322	0.00158	CcSEcCtD
Sildenafil—Arrhythmia—Carmustine—melanoma	0.000321	0.00157	CcSEcCtD
Sildenafil—Leukopenia—Bleomycin—melanoma	0.000321	0.00157	CcSEcCtD
Sildenafil—Dizziness—Vemurafenib—melanoma	0.000319	0.00157	CcSEcCtD
Sildenafil—Alopecia—Carmustine—melanoma	0.000317	0.00156	CcSEcCtD
Sildenafil—Angiopathy—Temozolomide—melanoma	0.000315	0.00154	CcSEcCtD
Sildenafil—Mental disorder—Carmustine—melanoma	0.000315	0.00154	CcSEcCtD
Sildenafil—Ataxia—Docetaxel—melanoma	0.000314	0.00154	CcSEcCtD
Sildenafil—Immune system disorder—Temozolomide—melanoma	0.000313	0.00154	CcSEcCtD
Sildenafil—Mediastinal disorder—Temozolomide—melanoma	0.000313	0.00153	CcSEcCtD
Sildenafil—Erythema—Carmustine—melanoma	0.000313	0.00153	CcSEcCtD
Sildenafil—Malnutrition—Carmustine—melanoma	0.000313	0.00153	CcSEcCtD
Sildenafil—Cough—Bleomycin—melanoma	0.000313	0.00153	CcSEcCtD
Sildenafil—Chills—Temozolomide—melanoma	0.000311	0.00153	CcSEcCtD
Sildenafil—Ill-defined disorder—Dactinomycin—melanoma	0.00031	0.00152	CcSEcCtD
Sildenafil—Anaemia—Dactinomycin—melanoma	0.000309	0.00151	CcSEcCtD
Sildenafil—Liver function test abnormal—Docetaxel—melanoma	0.000308	0.00151	CcSEcCtD
Sildenafil—Vomiting—Vemurafenib—melanoma	0.000307	0.0015	CcSEcCtD
Sildenafil—Alopecia—Temozolomide—melanoma	0.000307	0.0015	CcSEcCtD
Sildenafil—Chest pain—Bleomycin—melanoma	0.000305	0.0015	CcSEcCtD
Sildenafil—Myalgia—Bleomycin—melanoma	0.000305	0.0015	CcSEcCtD
Sildenafil—Abdominal pain upper—Docetaxel—melanoma	0.000305	0.00149	CcSEcCtD
Sildenafil—Orthostatic hypotension—Docetaxel—melanoma	0.000305	0.00149	CcSEcCtD
Sildenafil—Rash—Vemurafenib—melanoma	0.000304	0.00149	CcSEcCtD
Sildenafil—Mental disorder—Temozolomide—melanoma	0.000304	0.00149	CcSEcCtD
Sildenafil—Dermatitis—Vemurafenib—melanoma	0.000304	0.00149	CcSEcCtD
Sildenafil—Back pain—Carmustine—melanoma	0.000302	0.00148	CcSEcCtD
Sildenafil—Headache—Vemurafenib—melanoma	0.000302	0.00148	CcSEcCtD
Sildenafil—Malnutrition—Temozolomide—melanoma	0.000302	0.00148	CcSEcCtD
Sildenafil—Erythema—Temozolomide—melanoma	0.000302	0.00148	CcSEcCtD
Sildenafil—Breast disorder—Docetaxel—melanoma	0.000301	0.00148	CcSEcCtD
Sildenafil—Discomfort—Bleomycin—melanoma	0.000301	0.00148	CcSEcCtD
Sildenafil—Malaise—Dactinomycin—melanoma	0.000301	0.00148	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Docetaxel—melanoma	0.0003	0.00147	CcSEcCtD
Sildenafil—Leukopenia—Dactinomycin—melanoma	0.000299	0.00147	CcSEcCtD
Sildenafil—Nasopharyngitis—Docetaxel—melanoma	0.000298	0.00146	CcSEcCtD
Sildenafil—Vision blurred—Carmustine—melanoma	0.000295	0.00145	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Docetaxel—melanoma	0.000294	0.00144	CcSEcCtD
Sildenafil—Tremor—Carmustine—melanoma	0.000293	0.00144	CcSEcCtD
Sildenafil—Oedema—Bleomycin—melanoma	0.000292	0.00143	CcSEcCtD
Sildenafil—Back pain—Temozolomide—melanoma	0.000292	0.00143	CcSEcCtD
Sildenafil—Infection—Bleomycin—melanoma	0.00029	0.00142	CcSEcCtD
Sildenafil—Anaemia—Carmustine—melanoma	0.000289	0.00142	CcSEcCtD
Sildenafil—Dysphagia—Docetaxel—melanoma	0.000288	0.00141	CcSEcCtD
Sildenafil—Agitation—Carmustine—melanoma	0.000287	0.00141	CcSEcCtD
Sildenafil—Nausea—Vemurafenib—melanoma	0.000287	0.00141	CcSEcCtD
Sildenafil—Vision blurred—Temozolomide—melanoma	0.000285	0.0014	CcSEcCtD
Sildenafil—Myalgia—Dactinomycin—melanoma	0.000284	0.0014	CcSEcCtD
Sildenafil—Tremor—Temozolomide—melanoma	0.000283	0.00139	CcSEcCtD
Sildenafil—CYP2D6—head—melanoma	0.000282	0.00244	CbGeAlD
Sildenafil—Discomfort—Dactinomycin—melanoma	0.000281	0.00138	CcSEcCtD
Sildenafil—Angina pectoris—Docetaxel—melanoma	0.000281	0.00138	CcSEcCtD
Sildenafil—Ill-defined disorder—Temozolomide—melanoma	0.00028	0.00138	CcSEcCtD
Sildenafil—Leukopenia—Carmustine—melanoma	0.00028	0.00137	CcSEcCtD
Sildenafil—Anaemia—Temozolomide—melanoma	0.000279	0.00137	CcSEcCtD
Sildenafil—Anorexia—Bleomycin—melanoma	0.000279	0.00137	CcSEcCtD
Sildenafil—Agitation—Temozolomide—melanoma	0.000278	0.00136	CcSEcCtD
Sildenafil—Hypotension—Bleomycin—melanoma	0.000273	0.00134	CcSEcCtD
Sildenafil—CYP1A1—lymph node—melanoma	0.000273	0.00237	CbGeAlD
Sildenafil—Oedema—Dactinomycin—melanoma	0.000273	0.00134	CcSEcCtD
Sildenafil—Malaise—Temozolomide—melanoma	0.000272	0.00134	CcSEcCtD
Sildenafil—Vertigo—Temozolomide—melanoma	0.000271	0.00133	CcSEcCtD
Sildenafil—Convulsion—Carmustine—melanoma	0.000271	0.00133	CcSEcCtD
Sildenafil—Infection—Dactinomycin—melanoma	0.000271	0.00133	CcSEcCtD
Sildenafil—Leukopenia—Temozolomide—melanoma	0.00027	0.00133	CcSEcCtD
Sildenafil—Hypertension—Carmustine—melanoma	0.00027	0.00132	CcSEcCtD
Sildenafil—Palpitations—Temozolomide—melanoma	0.000267	0.00131	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000266	0.00131	CcSEcCtD
Sildenafil—Myalgia—Carmustine—melanoma	0.000266	0.00131	CcSEcCtD
Sildenafil—Chest pain—Carmustine—melanoma	0.000266	0.00131	CcSEcCtD
Sildenafil—Anxiety—Carmustine—melanoma	0.000265	0.0013	CcSEcCtD
Sildenafil—Cough—Temozolomide—melanoma	0.000264	0.00129	CcSEcCtD
Sildenafil—Paraesthesia—Bleomycin—melanoma	0.000262	0.00129	CcSEcCtD
Sildenafil—Weight increased—Docetaxel—melanoma	0.000262	0.00129	CcSEcCtD
Sildenafil—Convulsion—Temozolomide—melanoma	0.000262	0.00128	CcSEcCtD
Sildenafil—Hypertension—Temozolomide—melanoma	0.000261	0.00128	CcSEcCtD
Sildenafil—Dyspnoea—Bleomycin—melanoma	0.000261	0.00128	CcSEcCtD
Sildenafil—Anorexia—Dactinomycin—melanoma	0.00026	0.00127	CcSEcCtD
Sildenafil—Pneumonia—Docetaxel—melanoma	0.000259	0.00127	CcSEcCtD
Sildenafil—Arthralgia—Temozolomide—melanoma	0.000257	0.00126	CcSEcCtD
Sildenafil—Myalgia—Temozolomide—melanoma	0.000257	0.00126	CcSEcCtD
Sildenafil—Infestation NOS—Docetaxel—melanoma	0.000257	0.00126	CcSEcCtD
Sildenafil—Infestation—Docetaxel—melanoma	0.000257	0.00126	CcSEcCtD
Sildenafil—Anxiety—Temozolomide—melanoma	0.000256	0.00126	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000255	0.00125	CcSEcCtD
Sildenafil—Oedema—Carmustine—melanoma	0.000255	0.00125	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000255	0.00125	CcSEcCtD
Sildenafil—Discomfort—Temozolomide—melanoma	0.000254	0.00125	CcSEcCtD
Sildenafil—Decreased appetite—Bleomycin—melanoma	0.000254	0.00125	CcSEcCtD
Sildenafil—Infection—Carmustine—melanoma	0.000253	0.00124	CcSEcCtD
Sildenafil—Acute coronary syndrome—Docetaxel—melanoma	0.000253	0.00124	CcSEcCtD
Sildenafil—Renal failure—Docetaxel—melanoma	0.000253	0.00124	CcSEcCtD
Sildenafil—Myocardial infarction—Docetaxel—melanoma	0.000252	0.00124	CcSEcCtD
Sildenafil—Neuropathy peripheral—Docetaxel—melanoma	0.000252	0.00124	CcSEcCtD
Sildenafil—Dry mouth—Temozolomide—melanoma	0.000252	0.00123	CcSEcCtD
Sildenafil—Stomatitis—Docetaxel—melanoma	0.000251	0.00123	CcSEcCtD
Sildenafil—Pain—Bleomycin—melanoma	0.00025	0.00123	CcSEcCtD
Sildenafil—Conjunctivitis—Docetaxel—melanoma	0.00025	0.00123	CcSEcCtD
Sildenafil—Tachycardia—Carmustine—melanoma	0.000249	0.00122	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000248	0.00122	CcSEcCtD
Sildenafil—Oedema—Temozolomide—melanoma	0.000247	0.00121	CcSEcCtD
Sildenafil—Infection—Temozolomide—melanoma	0.000245	0.0012	CcSEcCtD
Sildenafil—Anorexia—Carmustine—melanoma	0.000243	0.00119	CcSEcCtD
Sildenafil—Epistaxis—Docetaxel—melanoma	0.000242	0.00119	CcSEcCtD
Sildenafil—Nervous system disorder—Temozolomide—melanoma	0.000242	0.00119	CcSEcCtD
Sildenafil—Feeling abnormal—Bleomycin—melanoma	0.000241	0.00118	CcSEcCtD
Sildenafil—Skin disorder—Temozolomide—melanoma	0.000239	0.00118	CcSEcCtD
Sildenafil—Hypotension—Carmustine—melanoma	0.000238	0.00117	CcSEcCtD
Sildenafil—Hyperhidrosis—Temozolomide—melanoma	0.000238	0.00117	CcSEcCtD
Sildenafil—Decreased appetite—Dactinomycin—melanoma	0.000237	0.00116	CcSEcCtD
Sildenafil—Fatigue—Dactinomycin—melanoma	0.000235	0.00115	CcSEcCtD
Sildenafil—Anorexia—Temozolomide—melanoma	0.000235	0.00115	CcSEcCtD
Sildenafil—Pain—Dactinomycin—melanoma	0.000233	0.00114	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Carmustine—melanoma	0.000232	0.00114	CcSEcCtD
Sildenafil—Urticaria—Bleomycin—melanoma	0.000232	0.00114	CcSEcCtD
Sildenafil—Haemoglobin—Docetaxel—melanoma	0.000232	0.00114	CcSEcCtD
Sildenafil—Rhinitis—Docetaxel—melanoma	0.000231	0.00114	CcSEcCtD
Sildenafil—Body temperature increased—Bleomycin—melanoma	0.000231	0.00113	CcSEcCtD
Sildenafil—Haemorrhage—Docetaxel—melanoma	0.000231	0.00113	CcSEcCtD
Sildenafil—Insomnia—Carmustine—melanoma	0.000231	0.00113	CcSEcCtD
Sildenafil—Hypoaesthesia—Docetaxel—melanoma	0.00023	0.00113	CcSEcCtD
Sildenafil—Paraesthesia—Carmustine—melanoma	0.000229	0.00112	CcSEcCtD
Sildenafil—Pharyngitis—Docetaxel—melanoma	0.000229	0.00112	CcSEcCtD
Sildenafil—Urinary tract disorder—Docetaxel—melanoma	0.000228	0.00112	CcSEcCtD
Sildenafil—Dyspnoea—Carmustine—melanoma	0.000227	0.00112	CcSEcCtD
Sildenafil—Oedema peripheral—Docetaxel—melanoma	0.000227	0.00112	CcSEcCtD
Sildenafil—Somnolence—Carmustine—melanoma	0.000227	0.00111	CcSEcCtD
Sildenafil—Connective tissue disorder—Docetaxel—melanoma	0.000227	0.00111	CcSEcCtD
Sildenafil—Urethral disorder—Docetaxel—melanoma	0.000226	0.00111	CcSEcCtD
Sildenafil—Feeling abnormal—Dactinomycin—melanoma	0.000225	0.0011	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000225	0.0011	CcSEcCtD
Sildenafil—Insomnia—Temozolomide—melanoma	0.000223	0.00109	CcSEcCtD
Sildenafil—Gastrointestinal pain—Dactinomycin—melanoma	0.000223	0.00109	CcSEcCtD
Sildenafil—Visual impairment—Docetaxel—melanoma	0.000222	0.00109	CcSEcCtD
Sildenafil—Decreased appetite—Carmustine—melanoma	0.000222	0.00109	CcSEcCtD
Sildenafil—Paraesthesia—Temozolomide—melanoma	0.000221	0.00109	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Carmustine—melanoma	0.00022	0.00108	CcSEcCtD
Sildenafil—Dyspnoea—Temozolomide—melanoma	0.00022	0.00108	CcSEcCtD
Sildenafil—Somnolence—Temozolomide—melanoma	0.000219	0.00108	CcSEcCtD
Sildenafil—Erythema multiforme—Docetaxel—melanoma	0.000218	0.00107	CcSEcCtD
Sildenafil—Constipation—Carmustine—melanoma	0.000218	0.00107	CcSEcCtD
Sildenafil—Pain—Carmustine—melanoma	0.000218	0.00107	CcSEcCtD
Sildenafil—Dyspepsia—Temozolomide—melanoma	0.000217	0.00106	CcSEcCtD
Sildenafil—Eye disorder—Docetaxel—melanoma	0.000216	0.00106	CcSEcCtD
Sildenafil—Abdominal pain—Dactinomycin—melanoma	0.000215	0.00106	CcSEcCtD
Sildenafil—Body temperature increased—Dactinomycin—melanoma	0.000215	0.00106	CcSEcCtD
Sildenafil—Hypersensitivity—Bleomycin—melanoma	0.000215	0.00106	CcSEcCtD
Sildenafil—Decreased appetite—Temozolomide—melanoma	0.000214	0.00105	CcSEcCtD
Sildenafil—Cardiac disorder—Docetaxel—melanoma	0.000214	0.00105	CcSEcCtD
Sildenafil—Flushing—Docetaxel—melanoma	0.000214	0.00105	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Temozolomide—melanoma	0.000213	0.00104	CcSEcCtD
Sildenafil—Fatigue—Temozolomide—melanoma	0.000213	0.00104	CcSEcCtD
Sildenafil—Constipation—Temozolomide—melanoma	0.000211	0.00103	CcSEcCtD
Sildenafil—Pain—Temozolomide—melanoma	0.000211	0.00103	CcSEcCtD
Sildenafil—Feeling abnormal—Carmustine—melanoma	0.00021	0.00103	CcSEcCtD
Sildenafil—Asthenia—Bleomycin—melanoma	0.00021	0.00103	CcSEcCtD
Sildenafil—Angiopathy—Docetaxel—melanoma	0.000209	0.00103	CcSEcCtD
Sildenafil—Gastrointestinal pain—Carmustine—melanoma	0.000209	0.00102	CcSEcCtD
Sildenafil—Immune system disorder—Docetaxel—melanoma	0.000208	0.00102	CcSEcCtD
Sildenafil—Mediastinal disorder—Docetaxel—melanoma	0.000208	0.00102	CcSEcCtD
Sildenafil—Chills—Docetaxel—melanoma	0.000207	0.00102	CcSEcCtD
Sildenafil—Pruritus—Bleomycin—melanoma	0.000207	0.00101	CcSEcCtD
Sildenafil—Arrhythmia—Docetaxel—melanoma	0.000206	0.00101	CcSEcCtD
Sildenafil—Alopecia—Docetaxel—melanoma	0.000204	0.001	CcSEcCtD
Sildenafil—Feeling abnormal—Temozolomide—melanoma	0.000203	0.000997	CcSEcCtD
Sildenafil—Mental disorder—Docetaxel—melanoma	0.000202	0.000992	CcSEcCtD
Sildenafil—Body temperature increased—Carmustine—melanoma	0.000202	0.00099	CcSEcCtD
Sildenafil—Abdominal pain—Carmustine—melanoma	0.000202	0.00099	CcSEcCtD
Sildenafil—Gastrointestinal pain—Temozolomide—melanoma	0.000202	0.000989	CcSEcCtD
Sildenafil—Erythema—Docetaxel—melanoma	0.000201	0.000986	CcSEcCtD
Sildenafil—Malnutrition—Docetaxel—melanoma	0.000201	0.000986	CcSEcCtD
Sildenafil—Hypersensitivity—Dactinomycin—melanoma	0.000201	0.000985	CcSEcCtD
Sildenafil—Urticaria—Temozolomide—melanoma	0.000196	0.000961	CcSEcCtD
Sildenafil—Asthenia—Dactinomycin—melanoma	0.000196	0.00096	CcSEcCtD
Sildenafil—Body temperature increased—Temozolomide—melanoma	0.000195	0.000956	CcSEcCtD
Sildenafil—Abdominal pain—Temozolomide—melanoma	0.000195	0.000956	CcSEcCtD
Sildenafil—Back pain—Docetaxel—melanoma	0.000194	0.000953	CcSEcCtD
Sildenafil—Hypersensitivity—Carmustine—melanoma	0.000188	0.000922	CcSEcCtD
Sildenafil—Diarrhoea—Dactinomycin—melanoma	0.000187	0.000915	CcSEcCtD
Sildenafil—Vomiting—Bleomycin—melanoma	0.000186	0.000912	CcSEcCtD
Sildenafil—Anaemia—Docetaxel—melanoma	0.000186	0.000911	CcSEcCtD
Sildenafil—Rash—Bleomycin—melanoma	0.000184	0.000904	CcSEcCtD
Sildenafil—Dermatitis—Bleomycin—melanoma	0.000184	0.000903	CcSEcCtD
Sildenafil—Asthenia—Carmustine—melanoma	0.000183	0.000898	CcSEcCtD
Sildenafil—Hypersensitivity—Temozolomide—melanoma	0.000182	0.000891	CcSEcCtD
Sildenafil—Syncope—Docetaxel—melanoma	0.00018	0.000884	CcSEcCtD
Sildenafil—Leukopenia—Docetaxel—melanoma	0.00018	0.000882	CcSEcCtD
Sildenafil—Palpitations—Docetaxel—melanoma	0.000178	0.000871	CcSEcCtD
Sildenafil—Asthenia—Temozolomide—melanoma	0.000177	0.000868	CcSEcCtD
Sildenafil—Loss of consciousness—Docetaxel—melanoma	0.000177	0.000866	CcSEcCtD
Sildenafil—Cough—Docetaxel—melanoma	0.000175	0.00086	CcSEcCtD
Sildenafil—Diarrhoea—Carmustine—melanoma	0.000175	0.000856	CcSEcCtD
Sildenafil—Pruritus—Temozolomide—melanoma	0.000174	0.000856	CcSEcCtD
Sildenafil—Convulsion—Docetaxel—melanoma	0.000174	0.000854	CcSEcCtD
Sildenafil—Nausea—Bleomycin—melanoma	0.000174	0.000852	CcSEcCtD
Sildenafil—Hypertension—Docetaxel—melanoma	0.000173	0.000851	CcSEcCtD
Sildenafil—Vomiting—Dactinomycin—melanoma	0.000173	0.00085	CcSEcCtD
Sildenafil—Rash—Dactinomycin—melanoma	0.000172	0.000843	CcSEcCtD
Sildenafil—Myalgia—Docetaxel—melanoma	0.000171	0.000839	CcSEcCtD
Sildenafil—Arthralgia—Docetaxel—melanoma	0.000171	0.000839	CcSEcCtD
Sildenafil—Chest pain—Docetaxel—melanoma	0.000171	0.000839	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00017	0.000833	CcSEcCtD
Sildenafil—Dizziness—Carmustine—melanoma	0.000169	0.000828	CcSEcCtD
Sildenafil—Diarrhoea—Temozolomide—melanoma	0.000169	0.000828	CcSEcCtD
Sildenafil—Dry mouth—Docetaxel—melanoma	0.000167	0.000821	CcSEcCtD
Sildenafil—Oedema—Docetaxel—melanoma	0.000164	0.000804	CcSEcCtD
Sildenafil—Dizziness—Temozolomide—melanoma	0.000163	0.0008	CcSEcCtD
Sildenafil—Infection—Docetaxel—melanoma	0.000163	0.000799	CcSEcCtD
Sildenafil—Vomiting—Carmustine—melanoma	0.000162	0.000796	CcSEcCtD
Sildenafil—Nausea—Dactinomycin—melanoma	0.000162	0.000794	CcSEcCtD
Sildenafil—Shock—Docetaxel—melanoma	0.000161	0.000791	CcSEcCtD
Sildenafil—Rash—Carmustine—melanoma	0.000161	0.000789	CcSEcCtD
Sildenafil—Nervous system disorder—Docetaxel—melanoma	0.000161	0.000789	CcSEcCtD
Sildenafil—Dermatitis—Carmustine—melanoma	0.000161	0.000789	CcSEcCtD
Sildenafil—Tachycardia—Docetaxel—melanoma	0.00016	0.000785	CcSEcCtD
Sildenafil—Headache—Carmustine—melanoma	0.00016	0.000784	CcSEcCtD
Sildenafil—Skin disorder—Docetaxel—melanoma	0.000159	0.000781	CcSEcCtD
Sildenafil—Vomiting—Temozolomide—melanoma	0.000157	0.000769	CcSEcCtD
Sildenafil—Anorexia—Docetaxel—melanoma	0.000156	0.000767	CcSEcCtD
Sildenafil—Rash—Temozolomide—melanoma	0.000155	0.000763	CcSEcCtD
Sildenafil—Dermatitis—Temozolomide—melanoma	0.000155	0.000762	CcSEcCtD
Sildenafil—Headache—Temozolomide—melanoma	0.000154	0.000758	CcSEcCtD
Sildenafil—Hypotension—Docetaxel—melanoma	0.000153	0.000752	CcSEcCtD
Sildenafil—Nausea—Carmustine—melanoma	0.000152	0.000744	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000149	0.000733	CcSEcCtD
Sildenafil—Insomnia—Docetaxel—melanoma	0.000148	0.000728	CcSEcCtD
Sildenafil—Paraesthesia—Docetaxel—melanoma	0.000147	0.000722	CcSEcCtD
Sildenafil—Nausea—Temozolomide—melanoma	0.000146	0.000719	CcSEcCtD
Sildenafil—Dyspnoea—Docetaxel—melanoma	0.000146	0.000717	CcSEcCtD
Sildenafil—Somnolence—Docetaxel—melanoma	0.000146	0.000715	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—melanoma	0.000144	0.000708	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—melanoma	0.000143	0.000699	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—melanoma	0.000142	0.000695	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—melanoma	0.000141	0.000694	CcSEcCtD
Sildenafil—Constipation—Docetaxel—melanoma	0.00014	0.000688	CcSEcCtD
Sildenafil—Pain—Docetaxel—melanoma	0.00014	0.000688	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—melanoma	0.000135	0.000663	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—melanoma	0.000134	0.000658	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—melanoma	0.00013	0.000636	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—melanoma	0.00013	0.000636	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—melanoma	0.000121	0.000593	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—melanoma	0.000118	0.000577	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—melanoma	0.000116	0.000569	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—melanoma	0.000112	0.00055	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—melanoma	0.000108	0.000532	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—melanoma	0.000104	0.000511	CcSEcCtD
Sildenafil—Rash—Docetaxel—melanoma	0.000103	0.000507	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—melanoma	0.000103	0.000507	CcSEcCtD
Sildenafil—Headache—Docetaxel—melanoma	0.000103	0.000504	CcSEcCtD
Sildenafil—Nausea—Docetaxel—melanoma	9.74e-05	0.000478	CcSEcCtD
Sildenafil—ABCC5—Disease—NRAS—melanoma	1.17e-05	9.44e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—melanoma	1.16e-05	9.36e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—melanoma	1.16e-05	9.35e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FN1—melanoma	1.14e-05	9.24e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNA11—melanoma	1.14e-05	9.23e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP17A1—melanoma	1.14e-05	9.21e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNA11—melanoma	1.14e-05	9.21e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLA2G6—melanoma	1.13e-05	9.15e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.13e-05	9.09e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLA2G6—melanoma	1.12e-05	9.07e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH1—melanoma	1.12e-05	9.04e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—melanoma	1.12e-05	9.04e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—FASN—melanoma	1.12e-05	9.03e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC6A11—melanoma	1.12e-05	9.01e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIP4K2A—melanoma	1.12e-05	9.01e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—FASN—melanoma	1.12e-05	9.01e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.11e-05	8.97e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—melanoma	1.11e-05	8.95e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—VCAN—melanoma	1.11e-05	8.93e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC5A5—melanoma	1.1e-05	8.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC5A5—melanoma	1.1e-05	8.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CD80—melanoma	1.1e-05	8.86e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—melanoma	1.1e-05	8.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KIT—melanoma	1.1e-05	8.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—melanoma	1.1e-05	8.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—melanoma	1.1e-05	8.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—melanoma	1.1e-05	8.84e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—melanoma	1.09e-05	8.79e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTAP—melanoma	1.09e-05	8.77e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGF—melanoma	1.08e-05	8.74e-05	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—melanoma	1.08e-05	8.73e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNA11—melanoma	1.08e-05	8.7e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PRKCA—melanoma	1.07e-05	8.6e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—melanoma	1.07e-05	8.6e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—melanoma	1.07e-05	8.6e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNAQ—melanoma	1.06e-05	8.58e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CD44—melanoma	1.06e-05	8.58e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—melanoma	1.06e-05	8.57e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNAQ—melanoma	1.06e-05	8.56e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CD44—melanoma	1.06e-05	8.56e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ERCC2—melanoma	1.06e-05	8.53e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—FASN—melanoma	1.05e-05	8.51e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—melanoma	1.05e-05	8.47e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.05e-05	8.46e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC5A5—melanoma	1.04e-05	8.37e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—melanoma	1.03e-05	8.31e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1B1—melanoma	1.02e-05	8.22e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—VCAN—melanoma	1.02e-05	8.22e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1B1—melanoma	1.02e-05	8.21e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.01e-05	8.16e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—VCAN—melanoma	1.01e-05	8.15e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—melanoma	1.01e-05	8.12e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1—melanoma	1e-05	8.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CD44—melanoma	1e-05	8.09e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNAQ—melanoma	1e-05	8.09e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—melanoma	9.98e-06	8.06e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—melanoma	9.98e-06	8.06e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.81e-06	7.92e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—melanoma	9.79e-06	7.9e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.72e-06	7.85e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAP2K1—melanoma	9.69e-06	7.82e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PHGDH—melanoma	9.68e-06	7.81e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LUM—melanoma	9.68e-06	7.81e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CD—melanoma	9.63e-06	7.77e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP1B1—melanoma	9.61e-06	7.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.55e-06	7.71e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—melanoma	9.54e-06	7.7e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HPSE—melanoma	9.49e-06	7.66e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—melanoma	9.43e-06	7.61e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP17A1—melanoma	9.34e-06	7.54e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CUBN—melanoma	9.32e-06	7.52e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—melanoma	9.24e-06	7.46e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.22e-06	7.44e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGF2—melanoma	9.22e-06	7.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.21e-06	7.43e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.09e-06	7.34e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SDHD—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BSG—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CSPG4—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNA11—melanoma	8.82e-06	7.12e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPAM—melanoma	8.72e-06	7.03e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—melanoma	8.66e-06	6.99e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—FASN—melanoma	8.63e-06	6.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MDM2—melanoma	8.63e-06	6.96e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP17A1—melanoma	8.59e-06	6.93e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—melanoma	8.55e-06	6.9e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP17A1—melanoma	8.52e-06	6.87e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—melanoma	8.51e-06	6.87e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A5—melanoma	8.49e-06	6.85e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.48e-06	6.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.4e-06	6.78e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—melanoma	8.39e-06	6.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—melanoma	8.39e-06	6.77e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—melanoma	8.37e-06	6.76e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—melanoma	8.35e-06	6.74e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.29e-06	6.69e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNAQ—melanoma	8.2e-06	6.62e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CD44—melanoma	8.2e-06	6.62e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—melanoma	8.19e-06	6.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNA11—melanoma	8.11e-06	6.55e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—melanoma	8.07e-06	6.51e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—melanoma	8.06e-06	6.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNA11—melanoma	8.04e-06	6.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.03e-06	6.48e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—melanoma	8.01e-06	6.47e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.96e-06	6.42e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—FASN—melanoma	7.94e-06	6.41e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—melanoma	7.91e-06	6.38e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—melanoma	7.88e-06	6.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—FASN—melanoma	7.87e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1B1—melanoma	7.86e-06	6.34e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—melanoma	7.81e-06	6.3e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—melanoma	7.79e-06	6.29e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—melanoma	7.74e-06	6.25e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—melanoma	7.74e-06	6.25e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PRKCA—melanoma	7.72e-06	6.23e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—melanoma	7.72e-06	6.23e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—melanoma	7.71e-06	6.22e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PRKCA—melanoma	7.71e-06	6.22e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—melanoma	7.67e-06	6.19e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ERCC2—melanoma	7.66e-06	6.18e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ERCC2—melanoma	7.64e-06	6.17e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—melanoma	7.55e-06	6.09e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNAQ—melanoma	7.54e-06	6.09e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CD44—melanoma	7.54e-06	6.09e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—melanoma	7.52e-06	6.07e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNAQ—melanoma	7.48e-06	6.03e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CD44—melanoma	7.48e-06	6.03e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—melanoma	7.44e-06	6.01e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G6—melanoma	7.41e-06	5.98e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—melanoma	7.34e-06	5.92e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.32e-06	5.91e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—melanoma	7.3e-06	5.89e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PRKCA—melanoma	7.28e-06	5.88e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—melanoma	7.27e-06	5.87e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.25e-06	5.85e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—melanoma	7.25e-06	5.85e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—melanoma	7.25e-06	5.85e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1B1—melanoma	7.23e-06	5.84e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ERCC2—melanoma	7.22e-06	5.83e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NFKB1—melanoma	7.22e-06	5.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1B1—melanoma	7.17e-06	5.79e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—melanoma	7.08e-06	5.71e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.94e-06	5.6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—VCAN—melanoma	6.66e-06	5.37e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—melanoma	6.55e-06	5.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—melanoma	6.49e-06	5.24e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—melanoma	6.47e-06	5.22e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—melanoma	6.47e-06	5.22e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—melanoma	6.4e-06	5.16e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—melanoma	6.34e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.33e-06	5.11e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—melanoma	6.32e-06	5.1e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—melanoma	6.2e-06	5e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—melanoma	6.05e-06	4.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—melanoma	6.04e-06	4.87e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—melanoma	6.03e-06	4.86e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.98e-06	4.83e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PRKCA—melanoma	5.96e-06	4.81e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—melanoma	5.95e-06	4.81e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ERCC2—melanoma	5.91e-06	4.77e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—melanoma	5.9e-06	4.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—melanoma	5.9e-06	4.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—melanoma	5.9e-06	4.76e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—melanoma	5.84e-06	4.71e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—melanoma	5.83e-06	4.7e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—melanoma	5.7e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP17A1—melanoma	5.62e-06	4.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—melanoma	5.57e-06	4.5e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—melanoma	5.53e-06	4.46e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—melanoma	5.5e-06	4.44e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PRKCA—melanoma	5.48e-06	4.42e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ERCC2—melanoma	5.43e-06	4.39e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PRKCA—melanoma	5.43e-06	4.38e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ERCC2—melanoma	5.39e-06	4.35e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—melanoma	5.32e-06	4.29e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—melanoma	5.31e-06	4.28e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNA11—melanoma	5.3e-06	4.28e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—melanoma	5.25e-06	4.24e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—melanoma	5.24e-06	4.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FASN—melanoma	5.19e-06	4.19e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—melanoma	5.12e-06	4.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—melanoma	5.11e-06	4.12e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—melanoma	5.01e-06	4.05e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—melanoma	4.95e-06	4e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—melanoma	4.95e-06	3.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNAQ—melanoma	4.93e-06	3.98e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CD44—melanoma	4.93e-06	3.98e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.89e-06	3.95e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—melanoma	4.73e-06	3.82e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1B1—melanoma	4.73e-06	3.82e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—melanoma	4.67e-06	3.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—melanoma	4.63e-06	3.74e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—melanoma	4.63e-06	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—melanoma	4.59e-06	3.71e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—melanoma	4.58e-06	3.7e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—melanoma	4.53e-06	3.66e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—melanoma	4.5e-06	3.63e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.46e-06	3.6e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—melanoma	4.37e-06	3.53e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—melanoma	4.33e-06	3.49e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—melanoma	4.29e-06	3.46e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—melanoma	4.26e-06	3.43e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—melanoma	4.18e-06	3.37e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—melanoma	4.14e-06	3.34e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—melanoma	4.11e-06	3.31e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—melanoma	4.1e-06	3.31e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—melanoma	4.05e-06	3.27e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—melanoma	4.01e-06	3.23e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—melanoma	4e-06	3.23e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—melanoma	3.9e-06	3.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—melanoma	3.89e-06	3.14e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—melanoma	3.78e-06	3.05e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—melanoma	3.77e-06	3.05e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—melanoma	3.74e-06	3.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—melanoma	3.72e-06	3.01e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—melanoma	3.69e-06	2.98e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PRKCA—melanoma	3.58e-06	2.89e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—melanoma	3.58e-06	2.89e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ERCC2—melanoma	3.55e-06	2.87e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—melanoma	3.54e-06	2.86e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—melanoma	3.29e-06	2.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—melanoma	3.26e-06	2.63e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—melanoma	3.26e-06	2.63e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—melanoma	3.23e-06	2.61e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—melanoma	3.19e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—melanoma	3.09e-06	2.49e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—melanoma	2.84e-06	2.29e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—melanoma	2.83e-06	2.28e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—melanoma	2.82e-06	2.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—melanoma	2.82e-06	2.27e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—melanoma	2.81e-06	2.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—melanoma	2.71e-06	2.19e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—melanoma	2.66e-06	2.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—melanoma	2.47e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—melanoma	2.44e-06	1.97e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—melanoma	2.31e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—melanoma	2.3e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—melanoma	2.18e-06	1.76e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—melanoma	2.18e-06	1.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—melanoma	2.15e-06	1.74e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—melanoma	2.13e-06	1.72e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—melanoma	2e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—melanoma	1.99e-06	1.6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—melanoma	1.86e-06	1.5e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—melanoma	1.78e-06	1.44e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—melanoma	1.64e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—melanoma	1.62e-06	1.31e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—melanoma	1.31e-06	1.06e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—melanoma	1.07e-06	8.64e-06	CbGpPWpGaD
